|September 24, 2013|
|13:25 EDT||NPSP, NPSP, NPSP||Leerink's biotech analyst holds an analyst/industry conference call|
Biotech Schwartz discusses the prospects for NPS Pharmaceuticals' (NPSP) Natpara ([rhPTH] 1-84) in Hypoparathyroidism on an Analyst/Industry conference call to be held on September 26 at 2 pm.
News For NPSP From The Last 14 Days
Check below for free stories on NPSP the last two weeks.
|December 11, 2013|
|07:35 EDT||NPSP||Elsevier Business Intelligence to hold a summit|
Subscribe for More Information
|December 10, 2013|
|07:41 EDT||NPSP||Oppenheimer to hold a conference|
24th Annual Healthcare Conference is being held in New York on December 10-11.
|December 3, 2013|
|14:39 EDT||NPSP||NPS Pharmaceuticals weakness attributed to comments on Natpara|
NPS Pharmaceuticals management said at a conference hosted by Deutshce Bank that it does not know if an FDA panel will be need for Natpara, according to Bloomberg. The company said it doesn't expect a priority review for Natpara, the news service added. Shares of NPS have fallen to session lows, down 7.7% to $24.04.
|07:09 EDT||NPSP||Deutsche Bank to host a conference|
BioFest is being held in Boston on December 2-3 with webcasted company presentations to begin on December 3 at 7:50 am; not all company presentations may be webcasted. Webcast Link
|December 2, 2013|
|12:34 EDT||NPSP||NPS Pharmaceuticals to hold an investor and analyst meeting|
Investor and Analyst Meeting is being held in New York on December 6 at 8:30 am. Webcast Link